Ramkumar Mandalam, Ph.D. is the President and CEO of Cellerant Therapeutics Inc, a clinical stage biotechnology company developing novel cell-based and antibody therapies for cancer treatment and blood-related disorders. Prior to joining Cellerant in 2005, he was the Executive Director of Product Development at Geron Corporation, a biopharmaceutical company in Menlo Park, CA. His responsibility at Geron included strategic planning and implementation of development and manufacturing of cellular products for regenerative medicine, oncology and drug discovery applications. Dr. Mandalam served as the Director of Developmental Research at Aastrom Biosciences managing research and development programs involving ex vivo expansion of human primary cells for cell therapy applications. Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan.